Browse Bentham Science Patent Journals:

Click the link and access the list of patent journals on various topics and fields: http://benthamscience.com/journal/browse-patent-journals.php?pcount=1

BSP Patent Journals: ‘Recent Patents on Biotechnology’ and ‘Recent Patents on Catalysis’

Editor-in-Chief:

ImageRongling Wu

Departments of Public Health Sciences and Statistics
Pennsylvania State College of Medicine
Hershey, PA
USA

Aims & Scope

Recent Patents on Biotechnology publishes review and research articles, and guest edited thematic issues on recent patents in the field of biotechnology. A selection of important and recent patents on biotechnology is also included in the journal. The journal is essential reading for all researchers involved in all fields of biotechnology.

Editor-in-Chief:

ImageShaobin Wang

Department of Chemical Engineering
Curtin University of Technology
Perth, WA 6845
Japan

Aims & Scope

Recent Patents on Catalysis publishes review, research articles and guest edited thematic issues on recent patents in the field of catalysis. The journal aims to provide recent patent information in all areas of catalysis science, including heterogeneous, homogeneous catalysis, synthesis and properties of new catalysts including synthesis and catalytic function of novel inorganic solids and complexes, studies that relate catalytic function to fundamental chemical processes in metal complexes and at surfaces, novel concepts in surface chemistry. A selection of important and recent patents on catalysis is also included in the journal. The journal is essential reading for all academic and industrial researchers, including IP authorities who wish to be kept informed about important patent breakthroughs in catalysis science and technology.

Podcast Broadcast!

A Brand New #Podcast! Click on! 
https://www.youtube.com/watch?v=dVgJ92oIukk

Title: The Recent Progress in RSV Vaccine Technology
Journal: Recent Patents on Anti-Infective Drug Discovery
Author: Doxa Kotzia
Vol.7, No.3, 2012

Abstract:

The most effective way to control RSV infection would be the development of an expedient and safe vaccine. Subunit vaccines, live attenuated RSV vaccines, plasmid DNA vaccines have been tested either in human or in mouse models without reaching the ultimate goal of efficacy and safety, at least in humans. Viruses such as adenovirus, sendai virus, measles virus were also used as vectors for the generation of RSV vaccines with promising results in animal models. Recent patents describe new techniques for the generation of candidate vaccines. These patents include virus like particles as vaccine platforms, recombinant RSVs or modified RSV F protein as component of the vaccine. Despite the number of the candidate vaccines, the new RSV vaccines should overcome many obstacles before being established as effective vaccines for the control of RSV infections especially for the young infants who are more susceptible to the virus.

For more information on the article: http://eurekaselect.com/103971/article

www.benthamscience.com

%d bloggers like this: